Clinical Trials for Lymphoplasmacytic Lymphoma

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

NCT ID: NCT00923507

This clinical trial is studying different blood cancers, including Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Lymphoplasmacytic Lym...

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT ID: NCT03314974

This clinical trial is studying a type of treatment called allogeneic hematopoietic stem cell transplant (HCT) for patients with various blood cancers, including leukemia and lymphoma. The aim is t...

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

NCT ID: NCT04840602

This clinical trial is testing a new treatment for patients with Waldenstrom's macroglobulinemia, a type of blood cancer. Researchers want to see if combining two medications, venetoclax and rituxi...

64Cu-LLP2A for Imaging Hematologic Malignancies

NCT ID: NCT06636175

This clinical trial is studying a new imaging agent called 64Cu-LLP2A, which is designed to help doctors see and understand certain blood cancers better. The trial focuses on patients with conditio...

A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia

NCT ID: NCT06986174

This clinical trial is studying a new medication called pacritinib to see how safe and effective it is for treating patients with Waldenström macroglobulinemia (WM), a type of blood cancer. The tri...

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

NCT ID: NCT06340737

This clinical trial is studying a new treatment called CD22 CAR T-cell therapy for adults with certain types of blood cancers known as B cell lymphomas. These cancers include follicular lymphoma, m...

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

NCT ID: NCT04883437

This clinical trial is studying a combination of two medications, acalabrutinib and obinutuzumab, to see how effective they are in treating patients with certain types of previously untreated indol...

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

NCT ID: NCT06860880

This clinical trial, titled "Combating Cancer-Related Fatigue: A Personalized Supportive Care Program," is designed to help patients with certain types of indolent lymphomas, including chronic lymp...

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

NCT ID: NCT04545762

This clinical trial is studying a new treatment using modified T cells, which are a type of immune cell from the patient's own body. These T cells have been genetically changed to better target and...

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

NCT ID: NCT04195633

This clinical trial is studying a new treatment approach for patients with various types of blood cancers, such as acute leukemia and lymphoma. The treatment combines a donor stem cell transplant w...

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

NCT ID: NCT05281809

This clinical trial is exploring a new method to produce and deliver CAR T-cell therapy for patients with certain types of B-cell cancers, including B-Cell Lymphoma and B-Acute Lymphoblastic Leukem...

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

NCT ID: NCT04488354

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

NCT ID: NCT01962636

This clinical trial is investigating a treatment called umbilical cord blood transplantation (UCBT) for patients with specific blood cancers, including different types of leukemia and lymphoma. The...

Study of SGR-1505 in Mature B-Cell Neoplasms

NCT ID: NCT05544019

This clinical trial is studying a new treatment called SGR-1505 for patients with various types of mature B-cell cancers, including Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia. The main g...